BEHRENS M KATHLEEN bought IGMS
June 30, 2025 · Form 4 insider transaction
BEHRENS M KATHLEEN bought 1,471 shares of IGM Biosciences Inc at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,471
Price
$0.00
Total value
N/A
InsiderBEHRENS M KATHLEEN
RoleDirector
CompanyIGM Biosciences Inc (IGMS)
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJune 30, 2025
Filing dateJuly 2, 2025
Shares owned after22,222
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
These securities are fully vested restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The amount reflects payment of a quarterly retainer in common stock pursuant to the Issuer's Outside Director Compensation Policy.